Nanoparticle News and Research

RSS

In nanotechnology, a particle is defined as a small object that behaves as a whole unit in terms of its transport and properties. It is further classified according to size: in terms of diameter, fine particles cover a range between 100 and 2500 nanometers, while ultrafine particles, on the other hand, are sized between 1 and 100 nanometers.

How to develop an "all-variant" COVID vaccine

In a recent study published in Nature Immunology, researchers summarized their observations of humoral immune responses elicited in severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) infected people. Additionally, they discussed all the types of SARS-CoV-2 infection- and vaccine-induced neutralizing antibodies (nAbs).

30 Jun 2022

Investigating PREVENT-19 trial findings of serological correlates of immune protection and risk against COVID-19

Researchers presented the PREVENT-19 phase 3 trial findings on the effectiveness of the NVX-CoV2373 adjuvanted, recombinant S nanoparticle vaccine.

27 Jun 2022

Biodegradable nanomaterials can take images and deliver medicine to combat peripheral arterial disease

A University of Texas at Arlington bioengineer is leading a project that will develop biodegradable nanomaterials that will take pictures and deliver medicine to combat peripheral arterial disease (PAD).

24 Jun 2022

Multifunctional nanoparticle system may be a promising therapeutic way for breast cancer therapy

In this new article publication from Acta Pharmaceutica Sinica B, authors Yun Yang, Danrong Hu, Yi Lu, Bingyang Chu, Xinlong He, Yu Chen, Yao Xiao, Chengli Yang, Kai Zhou, Liping Yuan and Zhiyong Qian from Sichuan University, Chengdu discuss tumor-targeted/reduction-triggered composite multifunctional nanoparticles for breast cancer chemo-photothermal combinational therapy.

18 Jun 2022

Machine learning predictive model for screening of LNP-based mRNA vaccines

In this new article publication from Acta Pharmaceutica Sinica B, authors Wei Wang, Shuo Feng, Zhuyifan Ye, Hanlu Gao, Jinzhong Lin and Defang Ouyang from University of Macau, Macau, China and Fudan University, Shanghai, China discuss the prediction of lipid nanoparticles for mRNA vaccines by machine learning algorithms.

18 Jun 2022

Novel nanoparticle therapeutics shows promise to fight solid tumors

Researchers from Wake Forest University School of Medicine have discovered a possible new approach to treating solid tumors through the creation of a novel nanoparticle. Solid tumors are found in cancers such as breast, head and neck, and colon cancer.

14 Jun 2022

Electronic nose detects SARS-CoV-2 from breath

Researchers discuss the development of an electronic nose device for the detection of SARS-CoV-2.

8 Jun 2022

New nanoparticles may pave the way for development of clinical sepsis therapy

Sepsis, the body's overreaction to an infection, affects more than 1.5 million people and kills at least 270,000 every year in the U.S. alone.

6 Jun 2022

CRISPR-based diagnostics for SARS-CoV-2 detection

In a recent study posted to the Journal of Biochemical and Molecular Toxicology, researchers reviewed clustered regularly interspaced short palindromic repeats (CRISPR)-based diagnostics for detecting severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).

6 Jun 2022

New, soft implantable probe can monitor fluctuations in brain chemicals

A new string-like implant can monitor fluctuations in brain chemicals, like a fitness tracker for the brain.

1 Jun 2022

Effectiveness of copper nanoparticle-based spray coating against SARS-CoV-2

Researchers demonstrate how copper NPs can potentially be incorporated into filters, PPE, facemasks, and clothing to effectively inactivate SARS-CoV-2.

31 May 2022

A polymer-nanoparticle hydrogel to subcutaneously deliver broadly neutralizing antibodies against SARS-CoV-2

Researchers compared the polymer-nanoparticle hydrogel system and standard routes of delivery of broadly neutralizing antibodies against SARS-CoV-2 in a mouse model.

27 May 2022

New approach could treat brain tumors and also prevent or delay recurrences

Scientists at the University of Michigan Rogel Cancer Center were optimistic when they identified a small molecule that blocked a key pathway in brain tumors.

27 May 2022

Development of a rapid, inexpensive and highly accurate diagnostic method to fight African Swine Fever

While the attention of public health authorities has been rivetted on the current COVID-19 pandemic, caused by the novel coronavirus SARS-CoV-2, many other viruses have been stealthily circling the globe, causing serious disease and death in humans and other animals.

25 May 2022

Association between reactogenicity and immunogenicity in SARS-CoV-2 mRNA-1273 vaccination

A recent study currently under review at Scientific Reports journal and posted to the Research Square* preprint server demonstrated a potential positive correlation between reactogenicity and immunogenicity of coronavirus disease 2019 (COVID-19) vaccination.

25 May 2022

Rapidly growing nanotechnology firm launches new identity as MIP Discovery

MIP Diagnostics, a leading UK nanotechnology firm has today rebranded to MIP Discovery as the business continues its expansion within the healthcare sector.

From MIP Discovery 19 May 2022

Broad-spectrum polymeric antivirals against SARS-CoV-2

In a recent study published in the journal Advanced Science, researchers evaluated the potential and applicability of macromolecular viral inhibitors against respiratory viral pathogens.

17 May 2022

Study could provide a new approach to treating metastatic triple negative breast cancer

Research from the University of Michigan Rogel Cancer Center could provide a new approach to treating an aggressive form of breast cancer.

12 May 2022

Phase 1 trial of COVID-19 PTXCOVID19-B vaccine

A new study demonstrated that the SARS-CoV-2 PTXCOVID19-B vaccine was a promising SARS-CoV-2 vaccine option.

12 May 2022

Researchers pursue a new way to use milk for delivering cancer-fighters to the brain

In health care, perhaps no word sends a more chilling message than "cancer." Brain tumors, for example, prove especially resistant to current treatments. Only 5% of patients with that condition survive more than three years and the median survival time is 10 to 14 months.

12 May 2022

Nanoparticle News and Research

Further Reading

How to develop an "all-variant" COVID vaccine

Investigating PREVENT-19 trial findings of serological correlates of immune protection and risk against COVID-19

Biodegradable nanomaterials can take images and deliver medicine to combat peripheral arterial disease

Multifunctional nanoparticle system may be a promising therapeutic way for breast cancer therapy

Machine learning predictive model for screening of LNP-based mRNA vaccines

Novel nanoparticle therapeutics shows promise to fight solid tumors

Electronic nose detects SARS-CoV-2 from breath

New nanoparticles may pave the way for development of clinical sepsis therapy

CRISPR-based diagnostics for SARS-CoV-2 detection

New, soft implantable probe can monitor fluctuations in brain chemicals

Effectiveness of copper nanoparticle-based spray coating against SARS-CoV-2

A polymer-nanoparticle hydrogel to subcutaneously deliver broadly neutralizing antibodies against SARS-CoV-2

New approach could treat brain tumors and also prevent or delay recurrences

Development of a rapid, inexpensive and highly accurate diagnostic method to fight African Swine Fever

Association between reactogenicity and immunogenicity in SARS-CoV-2 mRNA-1273 vaccination

Rapidly growing nanotechnology firm launches new identity as MIP Discovery

Broad-spectrum polymeric antivirals against SARS-CoV-2

Study could provide a new approach to treating metastatic triple negative breast cancer

Phase 1 trial of COVID-19 PTXCOVID19-B vaccine

Researchers pursue a new way to use milk for delivering cancer-fighters to the brain

Decoding Cannabis: Differentiating Hemp and Marijuana

Deciphering the Microbiome with The Microsetta Initiative

Leveraging the power of automation to boost research

Latest Life Science News